Table 1 Characteristics of quantitative studies measuring sexual dysfunction and psychosexual outcomes included in the review
From: Sexual dysfunction in women with genital warts: a systematic review
References | Country | Age (y) | Psychosexual outcomes measured | Number of participants | Survey instrument | Time of data collection | Study population | Comparison groups | Quality assessment score internal validity/external |
|---|---|---|---|---|---|---|---|---|---|
El-esawy et al. [20] | Egypt | 18–45 | (Sexual desire, arousal, lubrication, orgasm, satisfaction, and pain during intercourse) (Symptoms, feelings, routine daily activities, sports activities, work and school, personal relationships, and treatment) | 50 | Female sexual function index (FSFI) Dermatology life quality index (DLQI) | April to October 2016 | Married women with GWs that referred to the outpatient clinics of dermatology and andragogy department and gynecology and obstetrics department | None | ++ |
Nahidi et al. [19] | Iran | 18–64 | Sexual desire, arousal, lubrication, orgasm, satisfaction, and pain during intercourse Marital satisfaction | 74 | Arizona Sexual Experience Scale (ASEX) ENRICH Marital Satisfaction Scale | 2014 | AGW patients in the Imam Reza hospital at Mashhad | AGW Healthy persons | ++ |
Parkpinyo et al. [20] | Thailand | ≥ 18 | Sexual desire, arousal, lubrication, orgasm, satisfaction, and pain during intercourse | 47 | Thai version of Female Sexual Function Index (TFSFI) | May to December 2019 | Women with GWs in the Siriraj Female STI clinic | GW patients only | ++ |
Tas et al. [22] | Turkey | 18–54 | (Sexual desire, arousal, lubrication, orgasm, satisfaction, and pain during intercourse) depression | 100 | Arizona Sexual Experience Scale (ASEX) and BDI scale | September 2012 to April 2014 | Refugees of both sexes who attended dermatology clinic | GW patients only | ++ |
Campaneret al. [25] | Brazil | NR | Desire and sexual interest, foreplay, excitation of the woman, and harmonious interaction with partner comfort in sexual intercourse, orgasm, and sexual satisfaction | 75 | The Sexual Quotient-Female Version (SQ-F) Questionnaire | January 2011 to January 2012 | Women referred to the Clinic of Lower Genital Tract Diseases and Colposcopy | (1) GW (2) CIN2,3 | ++ |
Dominiak-Felden et al. [27] | UK | 18–64 | (Worries and concerns; emotional impact; sexual impact; self-image; partner issues and transmission; interactions with doctors; and health control and life impact) (Pleasure, desire/frequency, desire/interest, Arousal/excitement, and orgasm) (Dimensions—mobility, self-care, usual activities, pain/discomfort and anxiety/depression) | 842 | The HPV Impact Profile [HIP] questionnaire The Cuestionario Especifico en Condilomas Acuminados [CECA] The European Quality of Life Index Version 5D [EQ-5D] the Change in Sexual Functioning Questionnaire [CSFQ] VAS | May 2008 to March 2009 | Women with CIN1,2,3, VIN2,3 and GW who were referred to secondary care colposcopy and gynecology clinics | (1) Normal cervical cytology (2) Borderline nuclear abnormalities and/or mild dyskaryosis (3) CIN1/2/3 (4) VIN2/3 (5) GW (6) History of GW (7) Women in UK general population | ++ |
Canada | ≥ 18 | Health state, mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, mental health, The anogenital wart (AGW)-specific psychosocial burden (Self-image Sexual impact, Partner/transmission, Worries/Concerns, Emotional Impact, Interaction doctors, Control/Life impact | 272 | EuroQol EQ-5D VAS (SF)-12 SF-36 short version of the Spielberg State- rate anxiety Inventory HIP | September 2006 to February 2008 | Patients with a first or recurrent episode of AGW were recruited from the clinical practices of 42 physicians | (1) AGW Patients at recruitment time, 2 and 6 months later (2) age-matched Canadian norms | ++ | |
Escalaset al. [9] | Spain | 20–45 | Cognitive behavioral aspect, emotional experiences, psychic-physical well-being, and psychosexual sphere | 454 | CBA 2.0 (Cognitive Behavioral Assessment) | February 2006 to March 2007 | Women with HPV | (1) HPV+ (2) HPV− | + |
Kazeminejad et al. [21] | Iran | ≥ 16 | Physical function, social function, physical role playing, playing emotional role, mental health, vitality, physical pain, and general health Sexual impact | 65 | World Health Organization Quality of Life Brief Version (WHOQOL-BREF) | April 2017 to May 2018 | AGW Patients referred to Boali-sina Hospital in Sari, Iran | (1) AGW patients (2) Healthy persons | + |
Lee et al. [32] | South Korea | 20–60 | General health, sexual activity, cervical cancer screening behavior, psychosocial impact | 400 | HIP EQ-5D CECA VAS | July 2011 to 30 November 2011 | AGW patients referred to cervical cytology screenings clinics | (1) HPV related disease (AGW, abnormal pap. CIN…) (2) Healthy persons | ++ |
Piñeros et al. [12] | Columbia | 18–45 | Awareness and knowledge of HPV, sexual life, and self esteem | 342 | Questionnaire VAS scale | December 2009 to August 2010 | AGW patients | None | + |
Qi et al. [15] | China | 18–65 | Self-image, sexual impact, partner/transmission, worries/concerns, emotional impact, interaction with doctors, control/life impact | 521 | Questionnaire HIP | February to May 2008 | GW patients | None | ++ |
Woodhall et al. [28] | UK | ≥ 18 | impact of GWs on emotional and sexual wellbeing, economic evaluations, general health | 81 | Questionnaire EQ-5D EQ VAS CECA10 | NR | GW patients attending the York GUM clinic during a 3-month period | (1) GW (2) UK general Population | + |
Wang et al. [11] | Taiwan | 18–65 | Self-image, sexual impact, partner/transmission, worries/concerns, emotional impact, interaction with doctors, control/life impact | 249 | Questionnaire HIP | February to August 2006 | Women with an HPV-related diagnosis or intervention within the past 3 months | (1) Normal pap smear (2) CIN1,2,3 (3)ASCUS, LSIL, HSIL (4) GW (5) Abnormal pap+ hr HPV+ | ++ |
Sénécal et al. [29] | Canada | ≥ 18 | Mobility, usual activities, self-care, pain or discomfort and anxiety or depression self-image, sexual impact, partner/transmission, worries/concerns, emotional impact, interaction with doctors, control/life impact | 270 | EQ-5D HIP EQ-VAS | September 2006 to February 2008 | GW patients in initial or recurrent episode | (1) GW Patients at recruitment time, 2 and 6 months later (2) general Canadian, US and Alberta population | ++ |
Vriend et al. [26] | Netherlands |  | Mobility, usual activities, self-care, pain or discomfort, anxiety or depression Health status Sexual activity, and emotional impacts | 104 | EQ-5D EQ-VAS CECA-10 | February to August 2012 | GW patients Referred to 9 STI clinics | (1) GW Patients (2) General population (2000–2002) | + |